← Insider buys
PCVX

Vaxcyte, Inc. · Healthcare

Director Robert Lorne Hopfner sold $4.1M of Vaxcyte, Inc.

Sold$4,120,277
$28.30Price
145,612Shares
−7%Stake

What PCVX did after the filing

Prices for PCVX after this filing aren't in yet.

Traded Wed, Jan 6. Filed Fri, Jan 8, 12:17 PM ET, during the session. Not investment advice.